Stocks · Healthcare · Medical - Diagnostics & Research
Mettler-Toledo International Inc. MTD
$1,541.63 +3.73% Close, Oct 5, 2026 · NYSE · Market cap $30.03B
Low risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 10 quarters (average surprise over the last four: +4.2%).
- Revenue over the last four quarters was $4.13B, up 6.9% from a year earlier.
- Diluted EPS over the last four quarters was $44.43, up 12.5% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 45%
- EPS growth (TTM, YoY)Top 46%
- FCF growth (TTM, YoY)Bottom 42%
- Revenue growth, 3-year CAGRBottom 26%
- Revenue growth accelerationTop 43%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 2%
- Gross marginBottom 44%
- Operating marginTop 8%
- Cash conversion (OCF / net income)Bottom 24%
- Accruals (lower is better)Bottom 23%
- Net debt / EBITDA (lower is better)Bottom 45%
- Interest coverTop 10%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 19%
- Free-cash-flow yieldTop 26%
- EBITDA / enterprise valueTop 26%
- Sales / enterprise valueBottom 36%
- P/E vs own 5-year history (lower is better)Top 47%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 39%
- 6-month returnTop 39%
- 1-year return vs S&P 500Top 44%
- Distance from 52-week highTop 2%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 49%
- Consecutive EPS beatsTop 6%
- Share of analysts rating BuyBottom 10%
- Upside to consensus price targetBottom 9%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 6%
- Maximum drawdown, 3 yearsTop 10%
- Beta vs S&P 500 (lower is better)Top 39%
- Net debt / EBITDA (lower is better)Bottom 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.8% | 6.9% | ↑ |
| EPS growth (YoY) | 6.3% | 12.5% | ↑ |
| Gross margin | 58.1% | 58.4% | ↑ |
| Operating margin | 28.4% | 28.4% | ↑ |
| FCF margin | 21.9% | 20.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.9% | 6.8% | ↑ | Bottom 45% |
| EPS growth (TTM, YoY) | 12.5% | 6.3% | ↑ | Top 46% |
| Gross margin | 58.4% | 58.1% | ↑ | Bottom 44% |
| Operating margin | 28.4% | 28.4% | ↑ | Top 8% |
| Net margin | 21.9% | 21.5% | ↑ | — |
| Free-cash-flow margin | 20.9% | 21.9% | ↓ | — |
| Return on invested capital | 38.2% | — | Top 2% | |
| Revenue growth, 3-year CAGR | 0.9% | — | Bottom 26% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.08×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +0.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.58×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 16.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.50%
- Shareholder yield
- 2.50%
- Share count change, 1 year
- -2.8%
- Share count change, 3-year CAGR
- -3.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 31, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 10
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +4.2%
- Average 2-day reaction, last 8
- -1.7%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $1,466.29
- Target vs current price
- -4.9%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 42%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +5.6% | -0.6% | +2.4% | +0.7% | — |
| May 7, 2026 | +2.3% | -0.7% | -22.8% | -11.1% | +8.8% |
| Feb 5, 2026 | +4.4% | -0.5% | +0.2% | -9.2% | -8.8% |
| Nov 6, 2025 | +4.6% | -0.0% | +0.6% | -1.2% | -4.9% |
| Jul 31, 2025 | +5.1% | -2.5% | -3.5% | +1.5% | +13.6% |
| May 1, 2025 | +3.9% | -1.3% | +1.3% | +9.6% | +17.8% |
| Feb 6, 2025 | +5.9% | -0.5% | -3.7% | -6.7% | -19.3% |
| Nov 8, 2024 | +2.0% | -7.2% | -12.3% | -10.9% | -3.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $11.46 | $10.85 | +5.6% | $1.03B |
| May 7, 2026 | $8.91 | $8.71 | +2.3% | $947.1M |
| Feb 5, 2026 | $13.36 | $12.80 | +4.4% | $1.13B |
| Nov 6, 2025 | $11.15 | $10.66 | +4.6% | $1.03B |
| Jul 31, 2025 | $10.09 | $9.60 | +5.1% | $983.2M |
| May 1, 2025 | $8.19 | $7.88 | +3.9% | $883.7M |
| Feb 6, 2025 | $12.41 | $11.72 | +5.9% | $1.05B |
| Nov 8, 2024 | $10.21 | $10.01 | +2.0% | $954.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 34.7× | 35.3× | 43th | Top 19% |
| P/E (forward) | 32.6× | — | — | — |
| EV / EBITDA | 24.6× | — | — | Top 26% |
| EV / Sales | 7.76× | — | — | Bottom 36% |
| Free-cash-flow yield | 2.88% | — | — | Top 26% |
| Earnings yield | 2.88% | — | — | Top 19% |
P/E over the past five years
Range 26.1× – 49.3× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +18.5%
- Earnings per share growth (TTM)
- +12.5%
- Change in P/E multiple
- +5.1%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 14
- Days above the 200-day average
- 15
- 50-day average slope (20 days)
- +3.8%
- 200-day average slope (20 days)
- -0.0%
- Distance from 50-day average
- +9.1%
- Distance from 200-day average
- +16.8%
- RSI (14)
- 66.4
- Relative volume
- 0.78×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 26.9%
- Volatility vs own 5-year history
- 27th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.93
- Correlation with S&P 500
- 0.44
- Current drawdown from 1-year high
- -0.2%
- Maximum drawdown, 3 years
- -36.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 30, 2021 | Oct 30, 2023 | -43.5% | 460 days | Not yet recovered |
| Jan 20, 2021 | Mar 8, 2021 | -18.1% | 32 days | 28 days (Apr 16, 2021) |
| Sep 8, 2021 | Oct 12, 2021 | -15.5% | 24 days | 50 days (Dec 22, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $30.03B
- P/E (TTM)
- 34.7
- EPS, diluted (TTM)
- $44.43
- Revenue (TTM)
- $4.13B
- 52-week range
- $1,023.05 – $1,554.83
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.72B | $3.92B | $3.79B | $3.87B | $4.03B |
| Gross profit | $2.11B | $2.24B | $2.17B | $2.25B | $2.32B |
| Operating income | $994.7M | $1.13B | $1.08B | $1.13B | $1.12B |
| Net income | $769.0M | $872.5M | $788.8M | $863.1M | $869.2M |
| EPS (diluted) | $32.78 | $38.41 | $35.90 | $40.48 | $42.05 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $954.5M | $1.05B | $883.7M | $983.2M | $1.03B | $1.13B | $947.1M | $1.03B |
| Net income | $211.5M | $252.3M | $163.6M | $202.3M | $217.5M | $285.8M | $169.5M | $232.9M |
| EPS (diluted) | $9.96 | $11.96 | $7.81 | $9.76 | $10.57 | $13.98 | $8.33 | $11.55 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $908.8M | $859.1M | $965.9M | $968.3M | $955.8M |
| Capital expenditure | -$107.6M | -$121.2M | -$105.3M | -$103.9M | -$107.1M |
| Free cash flow | $801.2M | $737.8M | $860.6M | $864.4M | $848.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1000.0M | -$1.10B | -$900.0M | -$850.0M | -$767.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $51.4M
- Total assets
- $3.67B
- Total liabilities
- $3.66B
- Total debt
- $2.11B
- Net debt
- $2.06B
- Shareholders’ equity
- $12.8M
As of Jun 30, 2026 (filed Jul 31, 2026).
Short interest
- Shares sold short
- 697,792
- Days to cover
- 4.19
- Change vs previous report
- +10.0%
FINRA short interest, settlement date Sep 15, 2026.